Trials / Completed
CompletedNCT00230568
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aricept |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2007-04-01
- Completion
- 2007-12-01
- First posted
- 2005-10-03
- Last updated
- 2011-04-01
Locations
35 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00230568. Inclusion in this directory is not an endorsement.